Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Depreciation & Amortization (CF) (2018 - 2026)

TransMedics has reported Depreciation & Amortization (CF) over the past 8 years, most recently at $7.5 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 31.48% year-over-year to $7.5 million; the TTM value through Dec 2025 reached $27.1 million, up 38.42%, while the annual FY2025 figure was $27.2 million, 37.59% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $7.5 million at TransMedics, up from $6.8 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $7.5 million in Q4 2025 and troughed at $445000.0 in Q1 2021.
  • A 5-year average of $3.0 million and a median of $1.6 million in 2023 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): increased 2.87% in 2021 and later surged 230.92% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $466000.0 in 2021, then surged by 175.75% to $1.3 million in 2022, then soared by 180.54% to $3.6 million in 2023, then surged by 57.56% to $5.7 million in 2024, then surged by 31.48% to $7.5 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for TMDX at $7.5 million in Q4 2025, $6.8 million in Q3 2025, and $6.7 million in Q2 2025.